In line with the oncogenic role of FXR, Huang et al. observed that FXR promoted cancer cell proliferation, migration, and invasion via modulating CCNE2, a cell cycle regulator, in clear cell renal cell carcinoma (ccRCC) [135]. Here, NR1H4 is linked to nonpapillary renal cell carcinoma.